These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 11432822)
1. N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration. Nishi E; Prat A; Hospital V; Elenius K; Klagsbrun M EMBO J; 2001 Jul; 20(13):3342-50. PubMed ID: 11432822 [TBL] [Abstract][Full Text] [Related]
2. The metalloendopeptidase nardilysin (NRDc) is potently inhibited by heparin-binding epidermal growth factor-like growth factor (HB-EGF). Hospital V; Nishi E; Klagsbrun M; Cohen P; Seidah NG; Prat A Biochem J; 2002 Oct; 367(Pt 1):229-38. PubMed ID: 12095415 [TBL] [Abstract][Full Text] [Related]
3. Nardilysin enhances ectodomain shedding of heparin-binding epidermal growth factor-like growth factor through activation of tumor necrosis factor-alpha-converting enzyme. Nishi E; Hiraoka Y; Yoshida K; Okawa K; Kita T J Biol Chem; 2006 Oct; 281(41):31164-72. PubMed ID: 16923819 [TBL] [Abstract][Full Text] [Related]
4. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. Elenius K; Paul S; Allison G; Sun J; Klagsbrun M EMBO J; 1997 Mar; 16(6):1268-78. PubMed ID: 9135143 [TBL] [Abstract][Full Text] [Related]
5. Heparin-binding epidermal growth factor-like growth factor: hypoxia-inducible expression in vitro and stimulation of neurogenesis in vitro and in vivo. Jin K; Mao XO; Sun Y; Xie L; Jin L; Nishi E; Klagsbrun M; Greenberg DA J Neurosci; 2002 Jul; 22(13):5365-73. PubMed ID: 12097488 [TBL] [Abstract][Full Text] [Related]
6. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor. Kalmes A; Vesti BR; Daum G; Abraham JA; Clowes AW Circ Res; 2000 Jul; 87(2):92-8. PubMed ID: 10903991 [TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of transmembrane forms of heparin-binding EGF-like growth factor. no M; Raab G; Lau K; Abraham JA; Klagsbrun M J Biol Chem; 1994 Dec; 269(49):31315-21. PubMed ID: 7983076 [TBL] [Abstract][Full Text] [Related]
8. Characterization of sequences within heparin-binding EGF-like growth factor that mediate interaction with heparin. Thompson SA; Higashiyama S; Wood K; Pollitt NS; Damm D; McEnroe G; Garrick B; Ashton N; Lau K; Hancock N J Biol Chem; 1994 Jan; 269(4):2541-9. PubMed ID: 8300582 [TBL] [Abstract][Full Text] [Related]
9. Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor but not by EGF. Aviezer D; Yayon A Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12173-7. PubMed ID: 7991602 [TBL] [Abstract][Full Text] [Related]
10. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate. Higashiyama S; Abraham JA; Klagsbrun M J Cell Biol; 1993 Aug; 122(4):933-40. PubMed ID: 8349739 [TBL] [Abstract][Full Text] [Related]
11. Heparin-binding EGF-like growth factor interacts with mouse blastocysts independently of ErbB1: a possible role for heparan sulfate proteoglycans and ErbB4 in blastocyst implantation. Paria BC; Elenius K; Klagsbrun M; Dey SK Development; 1999 May; 126(9):1997-2005. PubMed ID: 10101133 [TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site. Suzuki M; Raab G; Moses MA; Fernandez CA; Klagsbrun M J Biol Chem; 1997 Dec; 272(50):31730-7. PubMed ID: 9395517 [TBL] [Abstract][Full Text] [Related]
13. The binding of HB-EGF to tumour cells is blocked by mAbs which act as EGF and TGF alpha antagonists. Modjtahedi H; Dean C Biochem Biophys Res Commun; 1995 Feb; 207(1):389-97. PubMed ID: 7857293 [TBL] [Abstract][Full Text] [Related]
14. Heparin-binding epidermal growth factor-like growth factor: p91 activation induction of plasminogen activator/inhibitor, and tubular morphogenesis in human microvascular endothelial cells. Ushiro S; Ono M; Izumi H; Kohno K; Taniguchi N; Higashiyama S; Kuwano M Jpn J Cancer Res; 1996 Jan; 87(1):68-77. PubMed ID: 8609052 [TBL] [Abstract][Full Text] [Related]
15. Interaction of heparin-binding EGF-like growth factor (HB-EGF) with the epidermal growth factor receptor: modulation by heparin, heparinase, or synthetic heparin-binding HB-EGF fragments. Besner GE; Whelton D; Crissman-Combs MA; Steffen CL; Kim GY; Brigstock DR Growth Factors; 1992; 7(4):289-96. PubMed ID: 1306684 [TBL] [Abstract][Full Text] [Related]
17. Acceleration of trophoblast differentiation by heparin-binding EGF-like growth factor is dependent on the stage-specific activation of calcium influx by ErbB receptors in developing mouse blastocysts. Wang J; Mayernik L; Schultz JF; Armant DR Development; 2000 Jan; 127(1):33-44. PubMed ID: 10654598 [TBL] [Abstract][Full Text] [Related]
18. Extracellular calcium influx stimulates metalloproteinase cleavage and secretion of heparin-binding EGF-like growth factor independently of protein kinase C. Dethlefsen SM; Raab G; Moses MA; Adam RM; Klagsbrun M; Freeman MR J Cell Biochem; 1998 May; 69(2):143-53. PubMed ID: 9548562 [TBL] [Abstract][Full Text] [Related]
19. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells. Wang YD; De Vos J; Jourdan M; Couderc G; Lu ZY; Rossi JF; Klein B Oncogene; 2002 Apr; 21(16):2584-92. PubMed ID: 11971193 [TBL] [Abstract][Full Text] [Related]
20. Nardilysin, a basic residues specific metallopeptidase that mediates cell migration and proliferation. Hospital V; Prat A Protein Pept Lett; 2004 Oct; 11(5):501-8. PubMed ID: 15544571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]